Nicolab
PrivateLast Round
Strategic
Apr 4, 2024
Est. Valuation
$140M
Total Funding Raised
$14.11M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Nicolab is a medtech company that provides StrokeViewer, an AI-powered platform designed to streamline emergency workflows and improve stroke diagnosis and treatment.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Telemedicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nicolab Comparables
Compare Nicolab with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RapidAI | 90% | |
| Brainomix | 88% | |
| Methinks AI | 87% | |
Nicolab Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Apr 4, 2024 | ||||
| VC Round | Dec 4, 2023 | ||||
| Grant | Feb 20, 2023 | ||||
| Series A | Apr 21, 2021 | ||||
| Grant | Jul 18, 2019 | ||||
Grant | Jul 1, 2018 |
Key People
Founding team and executive leadership
Nicolab Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fifth Estate Asset Management | Series A |
| European Innovation Council Fund | Grant |
| Canaccord Genuity | Series A |
| Regal Partners | Series A |
| Ellerston Capital | Series A |
| Perennial Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 60% MoM, reaching 2.2K.
- Feb 19, 2026
Grew 25% QoQ, from 36 to 45 employees.
Nicolab Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nicolab's valuation, stock price, and market status.